Why the consensus for consensus?

Journal of Pediatric Endocrinology and Metabolism

Volumn 21, Issue 6, 2008, Pages 503-505

  Rivkees, Scott A ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN DERIVATIVE; GROWTH HORMONE;

CONGENITAL ADRENAL HYPERPLASIA; CONSENSUS DEVELOPMENT; DIABETIC KETOACIDOSIS; DRUG INDUSTRY; DRUG USE; EDITORIAL; ENDOCRINOLOGY; INVESTMENT; PEDIATRICS; PRECOCIOUS PUBERTY; PUBLICATION; SEX DIFFERENTIATION DISORDER; SHORT STATURE; SMALL FOR DATE INFANT; VIRILIZATION; DISORDER OF SEX DEVELOPMENT; GROWTH DISORDER; HUMAN;

ADRENAL HYPERPLASIA, CONGENITAL; CHILD; CONSENSUS; CONSENSUS DEVELOPMENT CONFERENCES AS TOPIC; DIABETIC KETOACIDOSIS; ENDOCRINOLOGY; GONADOTROPIN-RELEASING HORMONE; GROWTH DISORDERS; HEALTH PLANNING GUIDELINES; HERMAPHRODITISM; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; PUBERTY, PRECOCIOUS; DISORDERS OF SEX DEVELOPMENT;

EID: 48449089521     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (20)

1. Crowley WFJ. Robert Blizzard Lecture: New genes that control puberty. Lawson Wilkins Pediatric Endocrine Society Annual Meeting, Honolulu, Hawaii, 2008.
2. Harrison L. Esoterix Lecture: An overview of approaches to the prevention of type 1 diabetes - from forbidden clones to regulatory cells. Lawson Wilkins Pediatric Endocrine Society Annual Meeting Honolulu, Hawaii, 2008.
3. McClintock M. Lawson Wilkins Lecture: The role of pheromones in human sexual behavior and function. Lawson Wilkins Pediatric Endocrine Society Annual Meeting, Honolulu, Hawaii, 2008.
4. Cohen P. Summary of Consensus Conference on ISS. Lawson Wilkins Pediatric Endocrine Society Annual Meeting, Honolulu, Hawaii, 2008.
5. Eugster EA. Summary of Consensus Conference on GnRH Analogs. Lawson Wilkins Pediatric Endocrine Society Annual Meeting, Honolulu, Hawaii, 2008.
6. Rapaport R. Summary of Consensus Conference on SGA. Lawson Wilkins Pediatric Endocrine Society Annual Meeting, Honolulu, Hawaii, 2008.
7. Clayton PE, Miller WL, Oberfield SE, Ritzen EM, Sippell WG, Speiser PW. Consensus statement on 21-hydroxylase deficiency from the European Society for Paediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine Society. Horm Res 2002; 58: 188-195.
8. Dunger DB, Sperling MA, Acerini CL, Bohn DJ, Daneman D, Danne TP, Glaser NS, Hanas R, Hintz RL, Levitsky LL, Savage MO, Tasker RC, Wolfsdorf JI. European Society for Paediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society consensus statement on diabetic ketoacidosis in children and adolescents. Pediatrics 2004; 113: e133-140.
9. Dunger DB, Sperling MA, Acerini CL, Bohn DJ, Daneman D, Danne TP, Glaser NS, Hanas R, Hintz RL, Levitsky LL, Savage MO, Tasker RC, Wolfsdorf JI. ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents. Arch Dis Child 2004; 89: 188-194.
10. Wolfsdorf J, Craig ME, Daneman D, Dunger D, Edge J, Lee WR, Rosenbloom A, Sperling MA, Hanas R International Society for Pediatric and Adolescent Diabetes. Diabetic ketoacidosis. Pediatr Diabetes 2007; 8: 28-43.
11. Wolfsdorf J, Glaser N, Sperling MA. Diabetic ketoacidosis in infants, children, and adolescents: a consensus statement from the American Diabetes Association. Diabetes Care 2006; 29: 1150-1159.
12. Houk CP, Hughes IA, Ahmed SF, Lee PA. Summary of consensus statement on intersex disorders and their management. International Intersex Consensus Conference. Pediatrics 2006; 118: 753-757.
13. Hughes IA, Houk C, Ahmed SF, Lee PA. Consensus statement on management of intersex disorders. Arch Dis Child 2006; 91: 554-563.
14. Lee PA, Houk CP, Ahmed SF, Hughes IA. Consensus statement on management of intersex disorders. International Consensus Conference on Intersex. Pediatrics 2006; 119: e488-500.
15. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969; 44: 291-303.
16. Kaplowitz PB, Oberfield SE. Reexamination of the age limit for defining when puberty is precocious in girls in the United States: implications for evaluation and treatment. Drug and Therapeutics and Executive Committees of the Lawson Wilkins Pediatric Endocrine Society. Pediatrics 1999; 104: 936-941.
17. Comite F, Cutler GB Jr, Rivier J, Vale WW, Loriaux DL, Crowley WF Jr. Short-term treatment of idiopathic precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. A preliminary report. N Engl J Med 1991; 305: 1546-1550.
18. de Zegher F, Albertsson-Wikland K, Wilton P, Chatelain P, Jonsson B, Lofstrom, A, Butenandt O, Chaussain JL. Growth hormone treatment of short children born small for gestational age: metanalysis of four independent, randomized, controlled, multicentre studies. Acta Paediatr Suppl 1996; 417: 27-31.
19. Hopwood NJ, Hintz RL, Gertner JM, Attie KM, Johanson AJ, Baptista J, Kuntze J, Blizzard RM, Cara JF, Chernausek SP, et al. Growth response of children with non-growth-hormone deficiency and marked short stature during three years of growth hormone therapy. J Pediatr 1993; 123: 215-222.
20. Rumsfeld D. Department of Defense Briefing, 2002.